Bivacor artificial hearts saved human life for the first time in the world

The first patient with an artificial heart of Bivacor was discharged from the hospital after 5 days of life. With magnetic technology, it changes the future of heart failure treatment.

Australia has achieved a historical turning point in medical innovation. The first patient in the world to receive the artificial heart of Bivacor’s titanium, was discharged from the hospital after spending more than 5 days with this advanced device. The man, who had received this artificial heart during a six -hour surgery at St. Vincent Sydney Hospital in November last year, was finally transplanted after waiting for a donated heart and now improved.

The surgery was directed by Dr. Paul Yashneh, a cardiac and chest surgeon. The artificial heart of the Bivacor made of titanium is designed as a temporary solution for patients waiting for heart transplant; But doctors believe it has the potential to become a permanent replacement for the heart failure. Dr. Yashnesh says about the technology.

When Daniel Thames (inventor of this device) hit the key and the artificial heart turned on, I had a lot of excitement and anxiety. This device is really a sacred cup; It cannot be dismissed or rejected by the body.

Bivacor Cardiac Engineering Innovation; The role of magnetic float

The artificial heart of the Bivacor uses a magnetic suspension engine for blood pumping, which eliminates mechanical erosion and extends the life of the device. This technology provides blood circulation continuously and reduces the risk of blood clotting or structural failure. The device is designed by Australian biomedical engineer Daniel Thames whose motivation to build it from childhood experiences to work with water pumps next to his father, a piping. The death of his father due to heart failure made his determination to develop this technology and save human lives.

The patient recipient of this artificial heart was about a 5 -year -old man from New South Wales who had trouble doing even simple things like walking to the bathroom before surgery. Using the heart of Bivacor, he lived for more than 5 days until the donation heart was provided. Dr. Yasht says:

In the past, one -fourth people waiting for the transplant died, but now with devices like this, the situation has changed.

Experiments of this artificial heart were also expanded to the United States, and its first implant was conducted in July at the Texas Heart Institute. So far, four other patients in the US have received the device, though none have been discharged from the hospital like Australian patient. Thames predicts that in the coming years, artificial hearts will become a more common option, and the only current limit is to produce more of these devices.

A small but powerful device to save humanity

The heart of the Bivacor, weighing only 5 grams, is small enough to fit into the body of a 5 -year -old child and patients do not feel presence. It works with a rechargeable external battery that is connected to the chest and needs to be replaced every four hours. In the future, the wireless charging of this device will also be reviewed.

This success took place in the same hospital that had made Australia’s first heart transplant in year 6. Due to a 5 % reduction in heart transplantation in Australia over the past year and the death of about 5 people per year due to heart failure, Bivacor artificial heart can be a new hope for patients around the world. Doctors at Alfred Melbourne Hospital are also preparing for their first implant in mid -year.

Read on Gadget News: